Physician profile
Ryan Y Lee
NPI 1437348919
$6,200.04
in general payments reported to CMS, 2019-2025
49 companies · $1,342 in 2025
The $1,342 reported for 2025 was more than what 75% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,091 · 2020: $24.21 · 2021: $651 · 2022: $841 · 2023: $644 · 2024: $1,608 · 2025: $1,342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,593.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $687.95 | 2019-2025 | Prostep Mica, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Smith+Nephew, INC. | $671.50 | 2019-2025 | Collagenase Santyl, Bone Anchors With Arthroscopic Delivery System |
| Sportstek Medical, INC | $436.00 | 2019 | |
| Acumed LLC | $356.52 | 2024-2025 | Acumed, Acumed, Osteomed |
| Nevro Corp. | $291.25 | 2023-2024 | Senza |
| Integra Lifesciences Corporation | $247.39 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Abbvie INC. | $222.24 | 2021-2025 | |
| Aroa Biosurgery Incorporated | $218.30 | 2022-2025 | |
| Koya Medical, INC. | $180.69 | 2023 | Dayspring |
| Kerecis Limited | $167.81 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Boston Scientific Corporation | $167.00 | 2021-2025 | General - Pain Management |
| Averitas Pharma INC. | $153.87 | 2024-2025 | Qutenza |
| Trilliant Surgical LLC. | $150.96 | 2022 | |
| Advanced Oxygen Therapy INC. | $141.17 | 2021-2025 | Topical Oxygen Chamber For Extremities |
| Trimed, INC. | $139.72 | 2024 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.